Advertisement

U.S. Markets open in 4 hrs 36 mins

S&P Futures
5,968.25
+10.00(+0.17%)
Dow Futures
43,964.00
+63.00(+0.14%)
Nasdaq Futures
20,943.25
+49.25(+0.24%)
Russell 2000 Futures
2,412.50
+6.70(+0.28%)
Crude Oil
71.20
-0.49(-0.68%)
Gold
2,670.50
-5.80(-0.22%)

Applied Therapeutics, Inc. (APLT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

9.65

+0.02

(+0.21%)

At close: 04:00PM EST

9.40

-0.25

(-2.59%)

After hours:

07:30PM EST

Loading interactive chart...

GlobeNewswire
Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference
NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it will present at the 2024 UBS Global Healthcare Conference on Tuesday, November 12, 2024, at 7:15 a.m. PT in Rancho Palos Verdes, California. A live webcast for this event will be accessible on the Events page under the I
Zacks
Applied Therapeutics (APLT) Upgraded to Buy: Here's What You Should Know
Applied Therapeutics (APLT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Jackson Financial (JXN) Upgraded to Strong Buy: Here's What You Should Know
  Zacks
- Community Financial (CBU) Upgraded to Buy: Here's What You Should Know
  Zacks